[Effectiveness of the combined use of antioxidants and nucleic acid precursors in experimental myocardial infarct].
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D009694:Nucleic Acid Precursors / Q000627:therapeutic use*; D009696:Nucleic Acids / Q000627:therapeutic use*; D010743:Phospholipids / Q000378:metabolism; D011817:Rabbits; D014810:Vitamin E / Q000627:therapeutic use
D000975:Antioxidants; D009694:Nucleic Acid Precursors; D009696:Nucleic Acids; D010743:Phospholipids; D014810:Vitamin E; C013683:sodium nucleinate
Effektivnost' sochetannogo primeneniia antioksidantov i predshestvennikov nukleinovykh kislot pri éksperimental'nom infarkte miokarda.